InMed Pharmaceuticals Inc. Revenue 2021–2025
InMed Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2021 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- InMed Pharmaceuticals Inc. revenue for the quarter ending December 31, 2025 was 820188, a 26.22% decrease year-over-year.
- InMed Pharmaceuticals Inc. revenue for the twelve months ending December 31, 2025 was 4.3 M, a 5.80% decrease year-over-year.
- InMed Pharmaceuticals Inc. annual revenue for 2025 was 4.9 M, a 7.50% increase from 2024.
- InMed Pharmaceuticals Inc. annual revenue for 2024 was 4.6 M, a 11.18% increase from 2023.
- InMed Pharmaceuticals Inc. annual revenue for 2023 was 4.1 M, a 202.80% increase from 2022.
- InMed Pharmaceuticals Inc. annual revenue for 2022 was 1.4 M.
InMed Pharmaceuticals Inc. (INM) — Frequently Asked Questions
InMed Pharmaceuticals Inc. (INM) is a publicly traded US company. It has a market capitalization of $1M. In fiscal 2025 it reported revenue of $5M and net income of -$8M. Explore INM's stock price, financial statements, earnings history, margins and key ratios below.
What is InMed Pharmaceuticals Inc.'s market cap?
InMed Pharmaceuticals Inc. (INM) has a market capitalization of $1M.
What is the INM stock price?
INM trades at $1.51 (-1.31% on the day).
How much revenue does InMed Pharmaceuticals Inc. make?
InMed Pharmaceuticals Inc. reported revenue of $5M in fiscal 2025.
Is INM profitable?
In fiscal 2025, InMed Pharmaceuticals Inc. reported net income of -$8M.